D-0208-2025 Class III

Recalled by Appco Pharma LLC — Piscataway, NJ

FDA drug recall D-0208-2025 was initiated by Appco Pharma LLC on Jan 16, 2025 and is designated Class III. Reason for recall: Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet Affected quantity: 1380 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 29, 2025
Initiation Date
Jan 16, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1380 bottles

Product description

Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.

Reason for recall

Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet

Distribution pattern

Nationwide USA.

Code information

Lot #: 2402101UR, Exp 02/28/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0208-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0208-2025. Report a data issue: hello@regdatalab.com.